Tue, September 8, 2009
Mon, September 7, 2009
Fri, September 4, 2009
Thu, September 3, 2009
Wed, September 2, 2009
Tue, September 1, 2009
Mon, August 31, 2009
Sun, August 30, 2009
Fri, August 28, 2009
Thu, August 27, 2009
Wed, August 26, 2009
Tue, August 25, 2009
Mon, August 24, 2009
Sun, August 23, 2009
Fri, August 21, 2009
Thu, August 20, 2009
Wed, August 19, 2009
Tue, August 18, 2009
Mon, August 17, 2009
Sun, August 16, 2009
Fri, August 14, 2009
Thu, August 13, 2009
Wed, August 12, 2009
Tue, August 11, 2009
Mon, August 10, 2009
Sun, August 9, 2009
Fri, August 7, 2009
Thu, August 6, 2009
Wed, August 5, 2009
Tue, August 4, 2009
Mon, August 3, 2009
Fri, July 31, 2009
Thu, July 30, 2009
Wed, July 29, 2009
Tue, July 28, 2009
Mon, July 27, 2009
Fri, July 24, 2009
Thu, July 23, 2009
Wed, July 22, 2009
Tue, July 21, 2009
Mon, July 20, 2009
Fri, July 17, 2009
Thu, July 16, 2009
Wed, July 15, 2009
Tue, July 14, 2009

CryoPort: CryoPort Raises $711,600 Through Shareholder Warrant Exercise


  Copy link into your clipboard //house-home.news-articles.net/content/2009/08/1 .. 11-600-through-shareholder-warrant-exercise.html
  Print publication without navigation Published in House and Home on , Last Modified on 2009-08-11 13:09:50 by Market Wire
          🞛 This publication is a summary or evaluation of another publication

LAKE FOREST, CA--(Marketwire - August 11, 2009) - CryoPort, Inc. (OTCBB: [ CYRX ]) today announced that it has received $711,600 from the exercise of warrants by current shareholders. The warrants were due to expire in July and early August.

"We are very pleased that the warrant holders continue to support our efforts as we move the company toward full commercialization," stated Larry G Stambaugh, CryoPort Chairman & CEO. "We have gotten indications from other current warrant holders that they too will exercise as additional warrants expire in August and September. This added level of financing will assist as we move toward a more significant capital raise and focus our energies on commercializing CryoPort's frozen shipping product. We thank and acknowledge our shareholders for their continued support of our efforts."

About CryoPort, Inc.

CryoPort ([ www.cryoport.com ]) is commercializing proprietary, technology-driven shipping products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain. The products developed by CryoPort are essential components of the infrastructure required for the clinical testing, research and end user deliver of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.

SAFE HARBOR

This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.


Publication Contributing Sources

Similar House and Home Publications